Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
LFMD
Strong SellSinkerLifeMD, Inc. · Healthcare · United States · $151M · Avg Vol: $3M/d
COMPANY DESCRIPTION
LifeMD, Inc. is a leading telehealth company that provides virtual primary and specialized healthcare services directly to consumers through its proprietary technology platform and network of affiliated clinicians. The company's competitive moat is built on its accessible direct-to-consumer model, which offers convenience and affordability for managing various chronic and acute conditions. LifeMD distinguishes itself by focusing on a broad range of specialized health programs, aiming to deliver comprehensive and personalized digital healthcare solutions.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 92.9M | 119.0M | 152.5M | 154.8M | 194.1M | 20.2% | 191.6M | 207.5M | 245.0M | 12.4% |
| EPS | -2.29 | -1.57 | -0.70 | -0.53 | 0.25 | — | -0.53 | 0.23 | — | -7.9% |
| Shares | 30.7M | 31.4M | 38.3M | 42.2M | 46.7M | +52.0% | 48.2M | — | — | — |
| Debt | 1.8M | 4.1M | 18.9M | 24.9M | 6.3M | 36.0% | 6.0M | — | — | — |
| Equity | 26.9M | -6.8M | 3.5M | -9.1M | 23.2M | -3.6% | — | — | — | — |
| Op CF | -33.1M | -22.9M | 8.8M | 17.5M | 8.3M | -3.1% | -6.7M | — | — | — |
| Inv CF | -3.4M | -13.9M | -8.7M | -11.5M | 6.9M | — | — | — | — | — |
| Fin CF | 68.6M | -0.5M | 29.1M | -4.1M | -13.4M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of LFMD are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| LFMD | LifeMD, Inc.(you) | $151M | 13 | Strong Sell |
| CHLT.TO | Custom Health Holdings Inc. | $135M | 11 | Strong Sell |
| DRIO | DarioHealth Corp. | $66M | 9 | Strong Sell |
| M7T.AX | Mach7 Technologies Limited | $54M | 23 | Sell |
| HCAT | Health Catalyst, Inc. | $120M | 39 | Hold |
| DH | Definitive Healthcare Corp. | $86M | 45 | Hold |
| NURS.V | Hydreight Technologies Inc. | $147M | 59 | Hold |
| CARL | Carlsmed, Inc. | $461M | 40 | Hold |
| EVH | Evolent Health, Inc. | $520M | 43 | Hold |
| MDRX | Veradigm Inc. | $517M | 51 | Hold |
Peer medians: ROE -30.5% · P/E 27.0x · Gross margin 58.1%